| 摘要 |
FIELD: medicine, pharmaceutics. ^ SUBSTANCE: invention refers to a compound of formula or to its pharmaceutically acceptable salts wherein -A-(R1)a means a group; -B-(R2)b means a group specified in the patent claim 1, R3 means hydrogen; X means CH2 or O; and Y means CH2. Also, the invention refers to a pharmaceutical composition exhibiting FGFR inhibitor activity on the basis of the declared compound. ^ EFFECT: there are produced new compounds and based pharmaceutical composition which can find application in medicine for preparing a cancer drug. ^ 8 cl, 1 tbl, 180 ex |
